evt | Article | August 2015
Sponsored by LimFlow, Inc.
evt | Article | May 2020
evt | News | November 5, 2019
DISAPEAR Registry Evaluates Abbott's Absorb BVS in Asian Cohort With CLTI
November 6, 2019—One-year results from the DISAPEAR registry evaluating the Absorb bioresorbable vascular scaffold (BVS; Abbott) were presented by Steven Kum, MD, in a late-breaking clinical trial session at VIVA 2019, the Vascular InterVentional Advances meeting held November 4–7 in Las Vegas, Nevada.
evt | News | August 1, 2017
Midterm Results Published From Pilot Study of LimFlow's pDVA System
August 1, 2017—LimFlow SA announced that midterm outcomes from the pilot study of the LimFlow percutaneous deep vein arterialization (pDVA) system for the treatment of no-option critical limb ischemia (CLI) were published online by Steven Kum, MD, et al in the Journal of Endovascular Therapy (JEVT).
evt | News | November 14, 2016
LimFlow System for Percutaneous Treatment of End-Stage CLI Receives CE Mark
November 15, 2016—LimFlow SA announced today it has received CE Mark approval for its fully percutaneous LimFlow System designed for venous arterialization of the lower limbs in end-stage patients at risk for limb amputation for critical limb ischemia (CLI).
evt | Article | May 2015
evt | News | October 5, 2015